Correlation of VEGF expression with prognostic factors of breast carcinoma
Background: Breast carcinoma is the most common malignant tumour and leading cause of cancer death among women worldwide. VEGF being a powerful mediator of angiogenesis, plays a major role in local growth as well as metastasis of many solid tumours including breast carcinoma. Objective: This study a...
Saved in:
Published in | Bangladesh journal of medical science (Ibn Sina Trust) Vol. 18; no. 3; pp. 513 - 518 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Dhaka
Ibn Sina Trust
2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background: Breast carcinoma is the most common malignant tumour and leading cause of cancer death among women worldwide. VEGF being a powerful mediator of angiogenesis, plays a major role in local growth as well as metastasis of many solid tumours including breast carcinoma.
Objective: This study aimed to evaluate the significance of VEGF expression in breast cancer and its correlation with prognostic parameters. Materials and methods: This study was conducted over a period of one year (February 2015 to January 2016). VEGF expression was evaluated in 57 histologically diagnosed cases of breast carcinoma with known ER and HER-2/neu status.
Result: Among 57 cases 52(91.2%) were positive for VEGF. Positive ER expression was seen in 39 cases which is 64.8% of total cases. 54% of the total cases were positive for HER-2/neu. VEGF expression was positively correlated (P value <0.05) with tumour grade, tumour size and negatively correlated with ER (p<0.005) and HER-2/neu (p<0.005). Significant correlation also found with tumour type (p<.005).
Conclusion: Considering the observations of the current study, it can be concluded that VEGF may play a crucial role in the pathogenesis of breast carcinoma and has a positive correlation with biologically aggressive tumour. So consideration of this biomarker (VEGF) is to be regarded as a prognostic parameter and critical evaluator of targeted chemotherapy
Bangladesh Journal of Medical Science Vol.18(3) 2019 p.513-518 |
---|---|
ISSN: | 2223-4721 2076-0299 |
DOI: | 10.3329/bjms.v18i3.41619 |